UTHR Exercise Disclosure
Mahon Paul A · SEC Form 4 · Filed Aug 6, 2026
Exercise
Calculated transaction value
$0
Mahon Paul A EVP & General Counsel
UTHR
Transaction date
Aug 6, 2026
Public filing date
Aug 6, 2026
Filing lag
Filed same day
UTHR daily price context
Close on/before transaction
$532.94
Aug 6, 2026
Close before public filing
$519.01
Aug 5, 2026
Return since public filing
-4.22%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 8,300 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001231589-26-000017
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$5.5M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 6, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $924.11K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $701.67K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $835.87K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $403.99K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $186.78K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $682.12K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $389.82K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $167.17K |
| United Therapeutics Corp UTHR Current | Exercise | Aug 6, 2026 | $0 |